Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.970
-0.140 (-4.50%)
At close: Nov 4, 2024, 4:00 PM
2.900
-0.070 (-2.36%)
After-hours: Nov 4, 2024, 7:53 PM EST

Purple Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
62227686714
Upgrade
Market Cap Growth
-58.19%-19.26%-60.76%1.95%364.70%30.76%
Upgrade
Enterprise Value
-25-622-07
Upgrade
Last Close Price
3.1115.6027.6077.8076.20155.92
Upgrade
PE Ratio
--173.68-230.31-743.47-312.98-516.21
Upgrade
PB Ratio
0.440.630.571.050.841.33
Upgrade
P/FCF Ratio
-0.73-1.09-1.60-4.45-5.48-2.58
Upgrade
P/OCF Ratio
-0.73-1.09-1.60-4.48-5.55-2.59
Upgrade
EV/EBITDA Ratio
-0.13-0.230.26-1.260.01-1.17
Upgrade
EV/EBIT Ratio
-0.13-0.230.26-1.240.01-1.13
Upgrade
EV/FCF Ratio
-0.15-0.260.35-1.450.01-1.28
Upgrade
Debt / Equity Ratio
0.010.010.010.010.010.02
Upgrade
Debt / FCF Ratio
-0.01-0.02-0.03-0.05-0.07-0.04
Upgrade
Quick Ratio
1.142.154.5511.1118.821.66
Upgrade
Current Ratio
1.222.204.7111.4119.142.34
Upgrade
Return on Equity (ROE)
-44.67%-49.09%-38.79%-24.61%-63.35%-49.47%
Upgrade
Return on Assets (ROA)
-29.25%-28.14%-22.50%-14.55%-16.74%-26.81%
Upgrade
Return on Capital (ROIC)
-33.77%-33.84%-24.75%-15.29%-17.98%-35.74%
Upgrade
Earnings Yield
-286.72%-91.76%-80.75%-26.88%-41.74%-40.53%
Upgrade
FCF Yield
-316.48%-91.98%-62.47%-22.47%-18.26%-38.74%
Upgrade
Buyback Yield / Dilution
-30.82%-22.41%-2.92%-52.76%-493.78%-36.34%
Upgrade
Total Shareholder Return
-30.82%-22.41%-2.92%-52.76%-493.78%-36.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.